Biofusion is wholly owned subsidiary of Biocon Limited engaged in research and development of novel molecules for targeted immuno-oncology therapy. Company's current focus is on dual-action biologics designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy.
Company Details
- Employees
- 6
- Founded
- 2021
- Address
- Biocon Park, Bangalore,karnataka,india
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Bangalore, Karnataka
Biofusion Therapeutics Questions
Biofusion Therapeutics's LinkedIn profile is https://in.linkedin.com/company/biofusion-therapeutics
Biofusion Therapeutics has
6 employees.
View email and phone details for 6
employees at Biofusion Therapeutics.
Biofusion Therapeutics's industry is
Biotechnology Research
Biofusion Therapeutics's top competitors are
Nkure Therapeutics,
Bicara Therapeutics,
Aragen Life Sciences,
Relicus Bio Pvt. Ltd.,
Aaarna Therapeutics,
Presude Lifesciences,
Pashi,
Primas Bioscience Private Limited,
Popvax,
Sekkei Bio Private Limited.
Biofusion Therapeutics's categories are Biotechnology Research
Biofusion Therapeutics's founding year is 2021
